New York University

Running trials

• Not yet recruiting

  COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"

  NCT07281027· Phase 3· Source

• Recruiting

  Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)

  NCT07665372· Source

• Not yet recruiting

  Signatera Assessment in Early-Stage Endometrial Cancer

  NCT07339384· Source

• Enrolling by invitation

  Simultaneous Measurement of EpicArdial and Microvascular ResisTance Via Angiographic FLOW Study

  NCT07676097· Source

• Recruiting

  A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132

  NCT06875960· Phase 4· Source

• Recruiting

  Zymfentra (Infliximab-dyyb) REal World Cohort STudy

  NCT07237516· Source

• Recruiting

  A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease

  NCT07041099· Phase 1· Source

• Recruiting

  Music Listening for Mental Health Recovery After Stroke

  NCT07127159· Source

• Recruiting

  The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study

  NCT05988385· Source

• Recruiting

  Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)

  NCT06263426· Source

• Recruiting

  Treatment With Endovascular Intervention for STroke Patients With Existing Disability

  NCT05911568· Source

• Active, not recruiting

  Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients

  NCT05669833· Phase 3· Source

• Recruiting

  Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

  NCT06311708· Source

• Active, not recruiting

  Team-based Care to Improve Hypertension

  NCT05413252· Source

• Recruiting

  Alleviant ALLAY-HF Study

  NCT05685303· Source

• Active, not recruiting

  Community-based Education, Navigation, and Support Intervention for Military Veterans

  NCT05343169· Source

• Active, not recruiting

  Observational Study in Patients With Cyclin-dependent Kinase-like 5 Deficiency Disorder

  NCT05373719· Source

• Active, not recruiting

  A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy

  NCT05316584· Source

• Recruiting

  Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma

  NCT05057702· Source

• Recruiting

  CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

  NCT05143996· Phase 1/2· Source

• Active, not recruiting

  EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy

  NCT04921787· Source

• Recruiting

  Combination Therapy for the Treatment of Diffuse Midline Gliomas

  NCT05009992· Phase 2· Source

• Active, not recruiting

  Centrally Acting ACE Inhibition in SLE

  NCT04486118· Phase 2· Source

• Recruiting

  RA-PRO PRAGMATIC TRIAL

  NCT04692493· Phase 3· Source

• Recruiting

  Parkinson's Foundation PD GENEration Genetic Registry

  NCT04994015· Source

• Recruiting

  Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

  NCT04485559· Phase 1· Source

• Recruiting

  Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

  NCT04410796· Phase 2· Source

• Recruiting

  Using tDCS in Speech-based Stroke Rehabilitation

  NCT03452202· Source

• Active, not recruiting

  Spinraza in Adult Spinal Muscular Atrophy

  NCT03709784· Source

• Active, not recruiting

  A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell Transplantation

  NCT03556332· Phase 2· Source

• Active, not recruiting

  A Single Center Diagnostic, Cross-sectional Study of Coronary Microvascular Dysfunction

  NCT03537586· Source

• Recruiting

  A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma

  NCT03334708· Source

• Recruiting

  Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal Carcinoma

  NCT03215719· Phase 2· Source

• Active, not recruiting

  Acoustic Stimulation for Seizure Suppression

  NCT03198494· Source

• Recruiting

  Modulating Movement Intention Via Cortical Stimulation

  NCT03233399· Source

• Active, not recruiting

  Evaluation of the Personal KinetiGraph™ (PKG™) to Improve Insight Into Parkinson's Disease Status

  NCT03741920· Source

• Active, not recruiting

  Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial

  NCT03108456· Source

• Active, not recruiting

  A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer

  NCT02989584· Phase 1/2· Source

• Active, not recruiting

  A Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Myeloma

  NCT02773030· Phase 1/2· Source

• Active, not recruiting

  Adjuvant PVX-410 Vaccine and Durvalumab in Stage II/III Triple Negative Breast Cancer

  NCT02826434· Phase 1· Source

• Active, not recruiting

  A Study of the ReCor Medical Paradise System in Clinical Hypertension

  NCT02649426· Source

• Recruiting

  Evaluation Of The Lung Microbiome In NTM Bronchiectasis

  NCT02779478· Source

• Recruiting

  Lung Microbiome and Inflammation in Early COPD

  NCT02777879· Source

• Active, not recruiting

  Innovative Approaches to Gauge Progression of Sturge-Weber Syndrome

  NCT01425944· Source

• Active, not recruiting

  Mediators of Atherosclerosis in South Asians Living in America

  NCT01207167· Source

• Recruiting

  Pompe Pregnancy Sub-Registry

  NCT00567073· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers3 recruiting
• Stroke3 recruiting
• COPD2 recruiting
• Epilepsy2 recruiting
• Heart failure2 recruiting
• HIV2 recruiting
• Acute myeloid leukemia1 recruiting
• Alzheimer disease1 recruiting
• Coronary artery disease1 recruiting
• Crohn's disease1 recruiting
• Endometrial cancer1 recruiting
• Head and neck cancer1 recruiting
• Lupus (SLE)1 recruiting
• Myelodysplastic syndromes1 recruiting
• Pompe disease1 recruiting
• Rheumatoid arthritis1 recruiting
• Sjögren's disease1 recruiting
• Ulcerative colitis1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Terminated

  A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma

  NCT05556616· Phase 1· Source

• Completed

  Phase 2 Study of DKN-01 in Colorectal Cancer

  NCT05480306· Phase 2· Source

• Completed

  Study 3 Learning Verbs and Pronouns

  NCT05193500· Source

• Terminated

  Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease

  NCT05267535· Phase 2/3· Source

• Terminated

  A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors

  NCT05070247· Phase 1/2· Source

• Completed

  Study 1 Replication and Extension of Prior Work

  NCT04166591· Source

• Completed

  HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis

  NCT04571619· Phase 2· Source

• Completed

  Study of CG0070 Given in Combination With Pembrolizumab, in Non-Muscle Invasive Bladder Cancer, Unresponsive to Bacillus Calmette-Guerin

  NCT04387461· Phase 2· Source

• Completed

  Study 2: Learning New Words From Overhearing in Children With Autism Spectrum Disorder (ASD)

  NCT05192109· Source

• Completed

  Medication Adherence With Telehealthcare Medication Therapy Management

  NCT03978936· Source

• Completed

  Greenlight Plus Study: Approaches to Early Childhood Obesity Prevention

  NCT04042467· Source

• Completed

  Symptom Management Efficacy Study to Reduce Distal Neuropathic Pain

  NCT03855111· Source

• Completed

  HOPE in Action Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients

  NCT03734393· Source

• Terminated

  Optic Nerve Head Structural Response to IOP Elevation in Patients With Keratoconus

  NCT03560609· Source

• Completed

  Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML

  NCT03258931· Phase 3· Source

• Terminated

  A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML

  NCT03547115· Phase 1· Source

• Completed

  Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial

  NCT03500328· Source

• Completed

  HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients

  NCT03500315· Source

• Completed

  Anti-viral Therapy in Alzheimer's Disease

  NCT03282916· Phase 2· Source

• Terminated

  WAveCrest Vs. Watchman TranssEptal LAA Closure to REduce AF-Mediated STroke 2

  NCT03302494· Phase 3· Source

• Completed

  Adolescent Master Protocol for Participants 18 Years of Age or Older - Lite

  NCT03279185· Source

• Completed

  CardiAMP™ Cell Therapy for Heart Failure Trial

  NCT02438306· Phase 3· Source

• Completed

  Study of MEK162 for Children With Low-Grade Gliomas

  NCT02285439· Phase 1/2· Source

• Completed

  Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1)

  NCT02583672· Phase 2· Source

• Completed

  Clinical Registry of Long-Term Dental Outcomes in Head and Neck Cancer Patients

  NCT05325970· Source

• Completed

  Surveillance Monitoring for ART Toxicities Study in HIV Uninfected Children Born to HIV Infected Women

  NCT01310023· Source

Trial sites

• New York University2 trials
• New York University41 trials
• New York University - College of Dentistry1 trial
• New York University, Division of Special Studies in Symptom Management1 trial
• New York University School of Medicine26 trials
• New York University School Of Medicine- Site Number : 8400401 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Alzheimer disease291 works · 3 trials
• HIV236 works · 8 trials
• Obesity216 works · 1 trials
• Stroke205 works · 4 trials
• Heart failure142 works · 3 trials
• Lung cancer125 works · 2 trials
• Epilepsy114 works · 3 trials
• Type 2 diabetes108 works · 0 trials
• Melanoma81 works · 0 trials
• Prostate cancer77 works · 0 trials
• Colorectal cancer75 works · 1 trials
• Pancreatic cancer68 works · 2 trials
• Multiple sclerosis64 works · 1 trials
• Chronic kidney disease64 works · 1 trials
• Schizophrenia63 works · 0 trials
• Parkinson disease61 works · 2 trials
• Asthma54 works · 1 trials
• Atrial fibrillation54 works · 1 trials
• Coronary artery disease53 works · 4 trials
• Cervical cancer48 works · 0 trials
• Depression46 works · 0 trials
• Lupus (SLE)45 works · 2 trials
• Autism43 works · 3 trials
• Glioblastoma35 works · 0 trials
• Psoriasis35 works · 1 trials
• Atopic dermatitis (eczema)34 works · 0 trials
• Rheumatoid arthritis27 works · 1 trials
• Crohn's disease26 works · 2 trials
• Ulcerative colitis24 works · 2 trials
• Endometrial cancer24 works · 1 trials